Registration - Amendment

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
JASON DUBOIS New —
JO ANNE GLISSON New —
JENNIFER BULLARD MADSEN New —
SCOTT VAN BUREN MCGOOHAN New —
ALAN MERTZ New —
FRANCESCA FIERRO O'REILLY New —

Health Issues HCR

Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
JASON DUBOIS New —
JO ANNE GLISSON New —
JENNIFER BULLARD MADSEN New —
SCOTT VAN BUREN MCGOOHAN New —
ALAN MERTZ New —
FRANCESCA FIERRO O'REILLY New —

Budget/Appropriations BUD

Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
JASON DUBOIS New —
JO ANNE GLISSON New —
JENNIFER BULLARD MADSEN New —
SCOTT VAN BUREN MCGOOHAN New —
ALAN MERTZ New —
FRANCESCA FIERRO O'REILLY New —

Medical/Disease Research/Clinical Labs MED

Medicare reimbursement for clinical laboratory services; health care reform law implementation issues including application of the medical device tax to clinical laboratories; closing the in-office ancillary services exception to the Stark Law; the regulation of laboratory developed tests; the coding and pricing of molecular pathology laboratory tests; reimbursement and coding issues related to the Clinical Laboratory Fee Schedule; and reimbursement and coding issues related to the Physician Fee Schedule.

LobbyistCovered position, as disclosed
JASON DUBOIS New —
JO ANNE GLISSON New —
JENNIFER BULLARD MADSEN New —
SCOTT VAN BUREN MCGOOHAN New —
ALAN MERTZ New —
FRANCESCA FIERRO O'REILLY New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.